Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
Pharmaceutics(2)
European Journal of Pharmaceutical Sciences(1)
Nanomedicine: Nanotechnology, Biology, and Medicine(1)
Pharmaceuticals(1)
Área temáticas
Farmacología y terapéutica(5)
Enfermedades(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Área de conocimiento
Farmacología(3)
Biomedicina(1)
Descubrimiento de fármacos(1)
Medicamento(1)
Medicina interna(1)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(5)
ODS 3: Salud y bienestar(5)
Origen
scopus(5)
Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation
ArticleAbstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment oPalabras claves:Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin DiseasesAutores:Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusFormulation strategies to improve nose-to-brain delivery of donepezil
ArticleAbstract: Donepezil (DPZ) is widely used in the treatment of Alzheimer’s disease in tablet form for oral adminPalabras claves:Alzheimer’s disease, Donepezil, Mucoadhesion, NANOEMULSIÓN, Nose-to-brain, Pluronic F-127Autores:Calpena A.C., Cañas M.A., Clares-Naveros B., Halbaut L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusNanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases
ArticleAbstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammatPalabras claves:anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disordersAutores:Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusThiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease
ArticleAbstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily uPalabras claves:Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, ThiazolidinedionesAutores:Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusTopical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model
ArticleAbstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show aPalabras claves:Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127Autores:Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.Fuentes:scopus